glp-1 receptor agonists and cancer risk in adults with obesity GLP-1s may reduce related risk, new research shows. Across large observational cohorts, they were linked to reduced rates of endometrial, liver, colorectal, other cancers. Learn more at the link The effect of GLP-1R agonists
Pay in 4 interest-free payments of $6.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30





























